期刊文献+

hTERT启动子调控的TRAIL基因载体的构建及表达

Construction and expression of TNF related apoptosis inducing ligand (TRAIL) gene driven by hTERT promoter
下载PDF
导出
摘要 目的:构建hTERT启动子调控的TRAIL基因载体,探讨hTERT启动子调控的转基因表达。方法:PCR法扩增膜结合型TRAIL基因,回收产物与带有hTERT启动子的载体连接,构建重组载体ph-TERT-TRAIL;瞬时转染乳腺癌细胞系MCF-7/ADR;采用RT-PCR法检测外源基因TRAILmRNA水平的表达,流式细胞术(FCM)检测蛋白水平的表达。结果:重组载体phTERT-TRAIL经PCR、酶切出现相应长度的片段;测序结果连入TRAIL基因;目的基因的序列分析结果与Genebank中的数据高度同源;RT-PCR显示细胞中外源基因TRAIL在mRNA水平明显表达;FCM显示转染了重组载体phTERT-TRAIL的细胞较未转染带有TRAIL基因载体的细胞TRAIL蛋白表达水平上调。结论:成功构建重组载体ph-TERT-TRAIL,hTERT启动子调控的TRAIL基因在乳腺癌细胞系MCF-7/ADR中明显表达。 Objective: To construct the TRAIL gene vector driven by hTERT promoter and explore its transgene expression from the hTERT promoter. Methods: The membrane-bound TRAIL gene was amplified by PCR. The products recycled were cloned into the vector carrying hTERT promoter and the recombinant phTERT-TRAIL was then constructed. The plasmids were transfected into breast cancer cell line MCF-7/ADR in vitro and the levels on mRNA and protein of foreign gene expression were detected by RT-PCR and FCM. Results: The PCR and enzyme digestion results of the recombinant plasmid phTERT-TRAIL showed the correct fragments,and the sequence analysis of targeted gene confirmed that it was highly conserved with that of that of the Genebank. The FCM results showed that the TRAIL protein expression level in cells transfected with phTERT-vector was higher than that non-transfectants or transfectants without TRAIL gene. Conclusion: The recombinant vector phTERT-TRAIL is constructed successfully. TRAIL gene driven by hTERT promoter can be obviously expressed in breast cancer cell line MCF-7/ADR.
出处 《山东大学学报(医学版)》 CAS 北大核心 2005年第1期17-21,共5页 Journal of Shandong University:Health Sciences
基金 山东大学预研课题(NO.213000)
关键词 启动区(遗传学) 基因表述 乳腺肿瘤 基因 TRAIL Promoter regions Gene cxpression Breast neoplasms Genes,TRAIL
  • 相关文献

参考文献10

  • 1郑晓飞,王升启.端粒与端粒酶研究进展[J].癌症,1997,16(6):464-467. 被引量:6
  • 2Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer[J]. Science, 1994, 266(5193):2011-2015.
  • 3Kagawa S, He C, Gu J, et al. Antitumor activity and bystander effects of the tumor necrosis factor related apoptosis-inducing ligand (TRAIL) gene [J]. Cancer Res, 2001, 61(8):3330-3338.
  • 4Wiley SR, Schooley K, Smolak P J, et al. Identification and characterization of a new member of the TNF family that induce apoptosis[J]. Immunity, 1995,3 (6):673-682.
  • 5Lu X, Arbiser JL, West J, et al. Tumor necrosis factor-related apoptosis-inducing ligand can induce apoptosis in subsets of premalignant cells [J]. Am J Pathol, 2004, 165(5):1613-1620.
  • 6Thomas WD, Hersey P. TNF - related apoptosis - inducing ligand(TRAIL) induces apoptosis in Fas ligand - resistant melanoma cells and mediates CD4 T cell killing of target cells [J]. J Immunol, 1998, 161(5) : 2195-2200.
  • 7Griffith TS , Chin WA , Jackson GC , et al. Intracellular regulation of TRAIL - induced apoptosis in human melanoma cell[J]. J Immunol, 1998, 161 (6):2833-2840.
  • 8Rieger J, Naumann U, Glaser T, et al. AP02 ligand :a novel lethal weapon against malignant glioma [J].FEBS Lett, 1998, 427(1):124-128.
  • 9Ichikawa K, Liu W, Zhao L, et al. Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity [J]. Nat Med 2001, 7(8):954-960.
  • 10Ruiz-Ruiz C, Lopez-Rivas A. Mitochondria-dependent and -independent mechanisms in tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis are both regulated by interferongamma in human breast tumour cells[J]. Biochem J,2002, 365(3):825-832.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部